There was some similarity with the spectrum of cancers associated with CHEK2 PTVs (eg, oesophageal cancer, DNHL, and melanoma being common), presumably reflecting their related roles in DNA damage response; notable differences are of the association with colon and lung cancer in ATM PTV carriers not seen in CHEK2. This evidence concerns the gene CHEK2 and carcinoma of esophagus.